Clinical Trial Update: Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome [Phase 3]

View source ↗

Summary

A Phase III randomized trial evaluating SYNSORB Pk for E. coli-associated Hemolytic Uremic Syndrome in children was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemolytic Uremic Syndrome

Drugs mentioned

• SYNSORB Pk

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hemolytic Uremic Syndrome | Phase 3 | Status: TERMINATED